Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Isolated New Zealanders deal with asset raising in different ways

Tuesday, March 30, 2010

From the Opalesque team: New Zealand, being so far away, has many courageous hedge fund managers. Courageous because they have to deal with the geographical isolation of their location as well as a local investor base that is not always open to sophisticated portfolio strategies. At the recent Opalesque New Zealand Roundtable (report here), some of these managers discussed how they handle such hurdles that are intrinsic to their beautiful country.

Enough of all this: NZ manager looking to leave London for Singapore “Right from the start of our business, we decided not to target New Zealand investors because firstly, we offer a very niche strategy; secondly, we thought to get local people to understand the strategy would be very difficult; and thirdly, that probably there would just not be the capital here for our kind of strategy,” said Anthony Limbrick, CIO of Pure Capital, a quantitatively driven investment manager.

But as due diligence trips to New Zealand (11 hours from Hong Kong, about 23 hours from London, 21 hours from New York) can be a deterrent to overseas investors, Pure set up a European office; a strategy which worked well, as the firm grew its assets from $10m two years ago to $43m.

But Limbrick is having second thoughts about being based in London: “We are seriously questioning our commitment to being in Europe. I am referring here to the plethora of re......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its